Optimization of Two-Indicator Screening Protocol for Neonatal Congenital Heart Disease at High Altitude

The requested reference [dad7e44da6af212dea959801e6b64b5cc6980c2f] no longer exists in our database. It has been replaced by the current reference: [4262e9377fe36e531703a7bc975649e1c1359b9b]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a prospective observational screening study. First, researchers will optimize a two-indicator screening protocol for neonatal congenital heart disease (NCHD) adapted to high-altitude regions and evaluate its screening accuracy. Second, researchers will compare the screening performance between the intelligent screening device and the optimized conventional manual screening, to preliminarily explore the value of this intelligent screening tool at high altitude. Finally, researchers will use descriptive qualitative research to deeply understand nurses\' real-world experience, operational barriers and training needs when using the plainland two-indicator protocol, the optimized high-altitude two-indicator protocol, and the intelligent screening device in high-altitude settings. Echocardiography will be used as the reference gold standard.
Epistemonikos ID: dd419916a94b5a8a42a4d2075735c35b7229055d
First added on: Oct 29, 2026